Pancreatic Cancer Therapy Area Pipeline Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Boston Therapeutics Inc

Boston Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Boston Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy

Nektar Therapeutics

Nektar Therapeutics

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Nektar Therapeutics compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Halozyme Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Ocera Therapeutics Inc

Ocera Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Ocera Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy | Countries: United States

Allergy Therapeutics PLC

Allergy Therapeutics PLC

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Allergy Therapeutics PLC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Transition Therapeutics, Inc.

Transition Therapeutics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 54 pages

A textual analysis of the financial results for Transition Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: Canada

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 50 pages

A textual analysis of the financial results for Enanta Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Regulus Therapeutics Incorporated

Regulus Therapeutics Incorporated

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 52 pages

A textual analysis of the financial results for Regulus Therapeutics Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Therapy

Opexa Therapeutics, Inc.

Opexa Therapeutics, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Opexa Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Hyperion Therapeutics Inc

Hyperion Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 52 pages

A textual analysis of the financial results for Hyperion Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.